文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Clinical Significance of the Lymph Node Ratio of the Second Operation to Predict Re-Recurrence in Thyroid Carcinoma.

作者信息

Park Joonseon, Kang Il Ku, Bae Ja Seong, Kim Jeong Soo, Kim Kwangsoon

机构信息

Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

出版信息

Cancers (Basel). 2023 Jan 19;15(3):624. doi: 10.3390/cancers15030624.


DOI:10.3390/cancers15030624
PMID:36765580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9913116/
Abstract

The purpose of this study was to establish the risk factors for re-recurrences and disease-specific mortality (DSM) in recurrent thyroid cancer. Patients with recurrent thyroid cancer who underwent initial thyroid surgery from January 2000 to December 2019 at Seoul St. Mary's Hospital (Seoul, Korea) were assessed. Clinicopathological characteristics and long-term oncologic outcomes were compared between patients with one recurrence ( = 202) and patients with re-recurrences ( = 44). Logistic regression and cox-regression analyses were conducted to determine the risk factors for re-recurrences and DSM, respectively. Receiver-operating characteristic curve analysis was performed to determine the cutoff value for lymph node ratio (LNR) as a predictor of re-recurrences. DSM was significantly higher in the re-recurrence group compared with the single-recurrence group (6.8% vs. 0.5%, = 0.019). Surgical treatment at the first recurrence significantly lowered the risk of re-recurrences. Age (≥55), male sex, and LNR (≥0.15) were independent significant risk factors for re-recurrences in patients who underwent surgery at the first recurrence. Surgical resection is the optimal treatment for initial thyroid cancer recurrence. LNR at re-operation is more effective in predicting re-recurrence than the absolute number of metastatic LNs.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/2c13d66d17b1/cancers-15-00624-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/fb032813343f/cancers-15-00624-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/655cb307b23e/cancers-15-00624-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/9928f6424350/cancers-15-00624-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/2c13d66d17b1/cancers-15-00624-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/fb032813343f/cancers-15-00624-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/655cb307b23e/cancers-15-00624-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/9928f6424350/cancers-15-00624-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b336/9913116/2c13d66d17b1/cancers-15-00624-g004.jpg

相似文献

[1]
Clinical Significance of the Lymph Node Ratio of the Second Operation to Predict Re-Recurrence in Thyroid Carcinoma.

Cancers (Basel). 2023-1-19

[2]
Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.

Cancers (Basel). 2023-5-27

[3]
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.

Int J Clin Oncol. 2016-10

[4]
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.

J Pediatr Surg. 2019-1

[5]
Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution.

Sci Rep. 2022-8-8

[6]
Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.

Clin Exp Otorhinolaryngol. 2018-3

[7]
Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.

World J Surg Oncol. 2022-9-30

[8]
Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.

Medicine (Baltimore). 2016-2

[9]
[Clinical features and prognoses of re-operated patients for persistent/recurrent papillary thyroid carcinoma].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022-9-7

[10]
Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.

Endocrine. 2022-12

引用本文的文献

[1]
BRAF V600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression.

Endocr Connect. 2025-7-30

[2]
Prognostic significance of elevated expression levels of protein phosphatase 1 regulatory subunit 3G in thyroid carcinoma.

Oncol Lett. 2024-11-28

[3]
Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.

Sci Rep. 2024-2-24

[4]
Risk factors and predictive model for recurrence in papillary thyroid carcinoma: a single-center retrospective cohort study based on 955 cases.

Front Endocrinol (Lausanne). 2023

[5]
Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.

Cancers (Basel). 2023-5-27

本文引用的文献

[1]
Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.

Oral Oncol. 2021-12

[2]
Evaluating the risk of re-recurrence in patients with persistent/recurrent thyroid carcinoma after initial reoperation.

Surgery. 2021-4

[3]
Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer.

Eur Thyroid J. 2020-2

[4]
Long-Term Declines of Thyroid Cancer Mortality: An International Age-Period-Cohort Analysis.

Thyroid. 2020-6

[5]
The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma.

Surgery. 2019-5-22

[6]
Indolent thyroid cancer: knowns and unknowns.

Cancers Head Neck. 2017-1-11

[7]
Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up.

Ann Surg Oncol. 2019-2-28

[8]
Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.

Head Neck. 2018-12-10

[9]
Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.

Head Neck. 2018-3-6

[10]
Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid.

Adv Anat Pathol. 2018-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索